⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14721708 | 0.89 | — | — | |
| Iodide SCHEMBL1730780 | 0.80 | — | — | |
| SCHEMBL3741580 | 0.80 | — | — | |
| SCHEMBL1260758 | 0.80 | — | — | |
| Hydrogen Sulfide SCHEMBL4563695 | 0.80 | — | — | |
| Methane SCHEMBL16504448 | 0.80 | — | — | |
| SCHEMBL2537100 | 0.80 | — | — | |
| Charcoal, Activated SCHEMBL446584 | 0.80 | — | — | |
| SCHEMBL3133498 | 0.80 | — | — | |
| SCHEMBL11619828 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150025601-A1 | PHOTOTHERAPY METHOD FOR TREATING PSORIASIS | FISET PETER D (US) | 2015-01-22 | — | — | US | disclosed |
| US-20130296978-A1 | Phototherapy Method for Treating Psoriasis | FISET PETER D (US) | 2013-11-07 | — | — | US | disclosed |
| US-20110212410-A1 | PHOTOTHERAPY METHOD FOR TREATING PSORIASIS | LEDEEP LLC | 2011-09-01 | — | — | US | disclosed |
| US-7921853-B2 | Phototherapy method for treating psoriasis | LEDEEP LLC (US) | 2011-04-12 | — | — | US | disclosed |
| US-20070276455-A1 | Phototherapy Systems And Methods | LEDEEP LLC (US) | 2007-11-29 | — | — | US | disclosed |
| EP-1735054-A2 | PHOTOTHERAPY SYSTEMS AND METHODS | Ledeep, LLC (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005086846-A2 | PHOTOTHERAPY SYSTEMS AND METHODS | LEDEEP, LLC (US) | 2005-09-22 | — | — | WO | disclosed |